跳至主要内容
临床试验/JPRN-UMIN000026767
JPRN-UMIN000026767已完成未知

Efficacy and safety of leukocytapheresis (LCAP) in combination with tacrolimus for active ulcerative colitis. - Efficacy and safety of LCAP with tacrolimus for ulcerative colitis.

Iwate Medical University0 个研究点目标入组 10 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

We could not accumulate appropriate patients for this study.

研究设计

研究类型
Observational

入排标准

年龄范围
16years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who satisfy the folloing any conditions (1)disease extent: rectal (2)leukocyte count < 3,000mm3 or platelet count < 100,000mm3 (3)diagnosed with fulminant UC (4)with deep or wide range ulceration, serious bleeding, performation, or toxic megacolon. (5)With severe cardiovascular, liver, kidney, respiratory, metabolic, or nervous diseases (6)Taking Anti-Angiotensin Converting Enzyme Antibody (7)Newly administerd or increased dose of thioprines within 8 weeks prior to LCAP (8)Administerd biological agents or Cyclosporin within 8 weeks prior to LCAP

研究者

相似试验